170 related articles for article (PubMed ID: 33523674)
1. Small-Molecule HSP27 Inhibitor Abolishes Androgen Receptors in Glioblastoma.
Li Y; Orahoske CM; Geldenhuys WJ; Bhattarai A; Sabbagh A; Bobba V; Salem FM; Zhang W; Shukla GC; Lathia JD; Wang B; Su B
J Med Chem; 2021 Feb; 64(3):1570-1583. PubMed ID: 33523674
[TBL] [Abstract][Full Text] [Related]
2. Lead Optimization of Androgen Receptor-HSP27 Disrupting Agents in Glioblastoma.
Li Y; Orahoske C; Salem F; Johnson A; Tannous C; Devole L; Zhang W; Lathia JD; Wang B; Su B
J Med Chem; 2023 Apr; 66(8):5567-5583. PubMed ID: 37023333
[TBL] [Abstract][Full Text] [Related]
3. Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.
Zoubeidi A; Zardan A; Beraldi E; Fazli L; Sowery R; Rennie P; Nelson C; Gleave M
Cancer Res; 2007 Nov; 67(21):10455-65. PubMed ID: 17974989
[TBL] [Abstract][Full Text] [Related]
4. Cedrol suppresses glioblastoma progression by triggering DNA damage and blocking nuclear translocation of the androgen receptor.
Chang KF; Huang XF; Chang JT; Huang YC; Weng JC; Tsai NM
Cancer Lett; 2020 Dec; 495():180-190. PubMed ID: 32987140
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor signaling regulates growth of glioblastoma multiforme in men.
Yu X; Jiang Y; Wei W; Cong P; Ding Y; Xiang L; Wu K
Tumour Biol; 2015 Feb; 36(2):967-72. PubMed ID: 25315188
[TBL] [Abstract][Full Text] [Related]
6. Advances in HSP27 and HSP90-targeting strategies for glioblastoma.
van Ommeren R; Staudt MD; Xu H; Hebb MO
J Neurooncol; 2016 Apr; 127(2):209-19. PubMed ID: 26842818
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.
Andrieu C; Taieb D; Baylot V; Ettinger S; Soubeyran P; De-Thonel A; Nelson C; Garrido C; So A; Fazli L; Bladou F; Gleave M; Iovanna JL; Rocchi P
Oncogene; 2010 Apr; 29(13):1883-96. PubMed ID: 20101233
[TBL] [Abstract][Full Text] [Related]
8. HSP27 knockdown produces synergistic induction of apoptosis by HSP90 and kinase inhibitors in glioblastoma multiforme.
Belkacemi L; Hebb MO
Anticancer Res; 2014 Sep; 34(9):4915-27. PubMed ID: 25202074
[TBL] [Abstract][Full Text] [Related]
9. A novel antiandrogen, Compound 30, suppresses castration-resistant and MDV3100-resistant prostate cancer growth in vitro and in vivo.
Kuruma H; Matsumoto H; Shiota M; Bishop J; Lamoureux F; Thomas C; Briere D; Los G; Gleave M; Fanjul A; Zoubeidi A
Mol Cancer Ther; 2013 May; 12(5):567-76. PubMed ID: 23493310
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor (AR) inhibitor ErbB3-binding protein-1 (Ebp1) is not targeted by the newly identified AR controlling signaling axis heat-shock protein HSP27 and microRNA miR-1 in prostate cancer cells.
Stope MB; Peters S; Großebrummel H; Zimmermann U; Walther R; Burchardt M
World J Urol; 2015 Mar; 33(3):323-7. PubMed ID: 24798454
[TBL] [Abstract][Full Text] [Related]
11. Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells.
Stope MB; Schubert T; Staar D; Rönnau C; Streitbörger A; Kroeger N; Kubisch C; Zimmermann U; Walther R; Burchardt M
World J Urol; 2012 Jun; 30(3):327-31. PubMed ID: 22362414
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Validation of Intratumoral Modulation Therapy for Glioblastoma.
Xu HU; Bihari F; Whitehead S; Wong E; Schmid S; Hebb MO
Anticancer Res; 2016 Jan; 36(1):71-80. PubMed ID: 26722029
[TBL] [Abstract][Full Text] [Related]
13. Quercetin sensitizes glioblastoma to t-AUCB by dual inhibition of Hsp27 and COX-2 in vitro and in vivo.
Li J; Tang C; Li L; Li R; Fan Y
J Exp Clin Cancer Res; 2016 Apr; 35():61. PubMed ID: 27039073
[TBL] [Abstract][Full Text] [Related]
14. Membrane-associated androgen receptor (AR) potentiates its transcriptional activities by activating heat shock protein 27 (HSP27).
Li J; Fu X; Cao S; Li J; Xing S; Li D; Dong Y; Cardin D; Park HW; Mauvais-Jarvis F; Zhang H
J Biol Chem; 2018 Aug; 293(33):12719-12729. PubMed ID: 29934310
[TBL] [Abstract][Full Text] [Related]
15. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME
Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
[TBL] [Abstract][Full Text] [Related]
16. Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma management.
Rajesh Y; Banerjee A; Pal I; Biswas A; Das S; Dey KK; Kapoor N; Ghosh AK; Mitra P; Mandal M
Biochim Biophys Acta Gen Subj; 2019 Jul; 1863(7):1196-1209. PubMed ID: 31028823
[TBL] [Abstract][Full Text] [Related]
17. Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
Costa B; Bendinelli S; Gabelloni P; Da Pozzo E; Daniele S; Scatena F; Vanacore R; Campiglia P; Bertamino A; Gomez-Monterrey I; Sorriento D; Del Giudice C; Iaccarino G; Novellino E; Martini C
PLoS One; 2013; 8(8):e72281. PubMed ID: 23977270
[TBL] [Abstract][Full Text] [Related]
18. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
19. The Jak2 small molecule inhibitor, G6, reduces the tumorigenic potential of T98G glioblastoma cells in vitro and in vivo.
Baskin R; Park SO; Keserű GM; Bisht KS; Wamsley HL; Sayeski PP
PLoS One; 2014; 9(8):e105568. PubMed ID: 25162558
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52.
Joshi JB; Patel D; Morton DJ; Sharma P; Zou J; Hewa Bostanthirige D; Gorantla Y; Nagappan P; Komaragiri SK; Sivils JC; Xie H; Palaniappan R; Wang G; Cox MB; Chaudhary J
Mol Oncol; 2017 Apr; 11(4):337-357. PubMed ID: 28252832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
